Rankings
▼
Calendar
IRWD Q1 2022 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$98M
+9.8% YoY
Gross Profit
$87M
88.9% margin
Operating Income
$58M
59.3% margin
Net Income
$39M
39.8% margin
EPS (Diluted)
$0.20
QoQ Revenue Growth
-16.7%
Cash Flow
Operating Cash Flow
$64M
Free Cash Flow
$64M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$566M
Stockholders' Equity
$518M
Cash & Equivalents
$593M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$98M
$89M
+9.8%
Gross Profit
$87M
$73M
+18.2%
Operating Income
$58M
$45M
+27.4%
Net Income
$39M
$40M
-2.8%
Revenue Segments
Collaborative arrangements revenue
$98M
98%
Collaborative arrangement, co-promotion agreements
$823,000
1%
Collaborative arrangement, other agreements
$480,000
0%
Collaborative arrangement, collaboration and license agreements
$192,000
0%
Geographic Segments
Canada and Mexico
$600,000
51%
North America
$582,000
49%
← FY 2022
All Quarters
Q2 2022 →